eplerenone

The medicine is used to treat heart failure, to prevent it from worsening and to reduce the risk of hospitalization. It is intended for people who have recently had a heart attack or who have persistent, mild symptoms despite ongoing treatment.

Form: tablets, film-coated

ATC: C03DA04

Manufacturer: Zentiva S.A.

Eleveon is used to treat heart failure to prevent it from worsening and to reduce the risk of hospitalization. It is intended for people who have recently had a heart attack or who have persistent, mild symptoms despite ongoing treatment.

Form: tablets, film-coated

ATC: C03DA04

Manufacturer: Zentiva S.A.

The medicine is used in the treatment of heart failure to prevent the worsening of the disease and to reduce the number of hospitalizations in people who have recently had a heart attack or have persistent mild symptoms despite current treatment.

Form: tablets, film-coated

ATC: C03DA04

Manufacturer: Krka, d.d., Novo mesto TAD Pharma GmbH

The medicine is used to treat heart failure to prevent the worsening of the disease and to reduce the number of hospitalizations in people who have recently had a heart attack or have persistent mild symptoms despite current treatment.

Form: tablets, film-coated

ATC: C03DA04

Manufacturer: Krka, d.d., Novo mesto TAD Pharma GmbH

The medicine is used to treat heart failure to prevent the disease from worsening and to reduce the number of hospitalizations. It is used in people after a heart attack (in combination with other medicines) or in patients with persistent, mild symptoms despite current treatment.

Form: tablets, film-coated

ATC: C03DA04

Manufacturer: G.L. Pharma GmbH, Pharmathen International S.A., Pharmathen S.A.

The medicine is used in the treatment of heart failure to prevent the worsening of the disease and to reduce the number of hospitalizations. It is used in people who have had a heart attack (in combination with other medicines) or when mild symptoms persist despite previous treatment.

Form: tablets, film-coated

ATC: C03DA04

Manufacturer: G.L. Pharma GmbH, Pharmathen International S.A., Pharmathen S.A.

The medicine is used in adult patients to reduce the risk of death or cardiovascular events. It is intended for individuals with stable left ventricular dysfunction (ejection fraction ≤ 40%) and symptoms of heart failure (edema) following a recent myocardial infarction.

Form: tablets

ATC: C03EB01

Manufacturer: Pharmaceutical Enterprise LEK-AM Ltd.

The medicine is used in adult patients to reduce the risk of death or cardiovascular events. It is intended for individuals with stable left ventricular dysfunction (ejection fraction ≤ 40%) and clinical symptoms of heart failure (edema) following a recent myocardial infarction.

Form: tablets

ATC: C03EB01

Manufacturer: Pharmaceutical Enterprise LEK-AM Ltd.

The medicine is used in the treatment of heart failure to prevent the worsening of the disease and to reduce the number of hospitalizations, especially in people after a heart attack or in patients with persistent, mild symptoms despite current treatment.

Form: tablets, film-coated

ATC: C03DA04

Manufacturer: Iasis Pharmaceuticals Hellas S.A.-Koropi

The medicine is used to treat heart failure to prevent the disease from worsening and to reduce the number of hospitalizations. It is used in people who have had a heart attack (in combination with other medicines) or when mild symptoms persist despite previous treatment.

Form: tablets, film-coated

ATC: C03DA04

Manufacturer: Iasis Pharmaceuticals Hellas S.A.-Koropi

The medicine is used in the treatment of heart failure to prevent its worsening and to reduce the number of hospitalizations, especially in people following a recent heart attack or in patients with persistent, mild symptoms despite current treatment.

Form: tablets, film-coated

ATC: C03DA04

Manufacturer: Medis International a.s.

The medicine is used in the treatment of heart failure to prevent its worsening and to reduce the number of hospitalizations. It is intended for individuals who have recently suffered a heart attack or for patients with persistent, mild symptoms of heart failure.

Form: tablets, film-coated

ATC: C03DA04

Manufacturer: Medis International a.s.

The medicine is used in the treatment of heart failure to prevent the worsening of the disease and to reduce the number of hospitalizations. It is used in people after a heart attack (in combination with other medicines) or in patients with persistent, mild symptoms despite current treatment.

Form: tablets, film-coated

ATC: C03DA04

Manufacturer: Polpharma Pharmaceutical Works S.A.

The medicine is used to treat heart failure to prevent the disease from worsening and to reduce the number of hospitalizations. It is recommended after a heart attack (in combination with other medicines) or when mild symptoms persist despite current treatment.

Form: tablets, film-coated

ATC: C03DA04

Manufacturer: Polpharma Pharmaceutical Works S.A.

The medicine is used to treat heart failure to prevent it from worsening and to reduce the number of hospitalizations. It is used in people who have recently suffered a heart attack (in combination with other medicines) or in patients with persistent, mild symptoms despite previous treatment.

Form: tablets, film-coated

ATC: C03DA04

Manufacturer: Fareva Amboise

The medicine is used to treat heart failure to prevent its worsening and to reduce the risk of hospitalization. It is intended for people who have recently had a heart attack or who continue to have mild symptoms despite ongoing treatment.

Form: tablets, film-coated

ATC: C03DA04

Manufacturer: Fareva Amboise

The medicine is used to treat heart failure to prevent it from worsening and to reduce the number of hospitalizations, especially after a recent heart attack or when mild symptoms persist despite current treatment.

Form: tablets, film-coated

ATC: C03DA04

Manufacturer: Adamed Pharma S.A.

The medicine is used in the treatment of heart failure to prevent its worsening and to reduce the number of hospitalizations, especially in individuals following a recent heart attack or in patients with persistent, mild symptoms.

Form: tablets, film-coated

ATC: C03DA04

Manufacturer: Adamed Pharma S.A.

The medicine is used in adult patients to reduce the risk of death and cardiovascular events. It is intended for individuals with stable left ventricular dysfunction (ejection fraction ≤ 40%) and clinical symptoms of heart failure (edema) following a recent myocardial infarction.

Form: tablets

ATC: C03EB01

Manufacturer: Pharmaceutical Enterprise LEK-AM Ltd.

The medicine is used in adult patients to reduce the risk of death and cardiovascular events. It is intended for individuals with stable left ventricular dysfunction (ejection fraction ≤ 40%) and clinical symptoms of heart failure (edema) following a recent myocardial infarction.

Form: tablets

ATC: C03EB01

Manufacturer: Pharmaceutical Enterprise LEK-AM Ltd.